BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 161 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $187,000 | -9.7% | 60,338 | +5.2% | 0.00% | – |
Q3 2021 | $207,000 | -5.5% | 57,350 | -6.1% | 0.00% | – |
Q2 2021 | $219,000 | -8.8% | 61,061 | -0.3% | 0.00% | – |
Q1 2021 | $240,000 | -14.9% | 61,261 | -9.0% | 0.00% | – |
Q4 2020 | $282,000 | +8.9% | 67,296 | -2.8% | 0.00% | – |
Q3 2020 | $259,000 | -57.9% | 69,224 | -50.9% | 0.00% | – |
Q2 2020 | $615,000 | +439.5% | 141,125 | +367.8% | 0.00% | – |
Q1 2020 | $114,000 | -98.4% | 30,167 | -97.3% | 0.00% | -100.0% |
Q4 2019 | $6,950,000 | +2012.5% | 1,099,960 | +1302.4% | 0.01% | – |
Q3 2019 | $329,000 | -88.9% | 78,433 | -87.7% | 0.00% | -100.0% |
Q2 2019 | $2,960,000 | -49.1% | 636,926 | -42.0% | 0.00% | -33.3% |
Q1 2019 | $5,816,000 | +18661.3% | 1,097,520 | +9791.1% | 0.00% | – |
Q3 2018 | $31,000 | -16.2% | 11,096 | -12.6% | 0.00% | – |
Q2 2018 | $37,000 | +3600.0% | 12,702 | +1497.7% | 0.00% | – |
Q1 2018 | $1,000 | -99.8% | 795 | -99.5% | 0.00% | – |
Q4 2017 | $456,000 | -73.1% | 154,964 | -73.1% | 0.00% | -100.0% |
Q3 2017 | $1,697,000 | +7.1% | 575,579 | +1.7% | 0.00% | 0.0% |
Q2 2017 | $1,584,000 | +192.3% | 565,834 | +98.0% | 0.00% | – |
Q1 2017 | $542,000 | +30.3% | 285,717 | +20.0% | 0.00% | – |
Q4 2016 | $416,000 | -86.0% | 238,000 | -78.3% | 0.00% | -100.0% |
Q3 2016 | $2,961,000 | -10.1% | 1,096,917 | -21.5% | 0.00% | 0.0% |
Q2 2016 | $3,295,000 | +183.6% | 1,396,524 | +287.5% | 0.00% | +100.0% |
Q1 2016 | $1,162,000 | +70.1% | 360,397 | +151.7% | 0.00% | – |
Q4 2015 | $683,000 | +3.5% | 143,163 | +20.1% | 0.00% | -100.0% |
Q3 2015 | $660,000 | +26.2% | 119,164 | +80.5% | 0.00% | – |
Q2 2015 | $523,000 | -26.0% | 66,034 | -2.2% | 0.00% | – |
Q1 2015 | $707,000 | +123.7% | 67,520 | +156.0% | 0.00% | – |
Q4 2014 | $316,000 | -72.6% | 26,376 | -60.9% | 0.00% | -100.0% |
Q3 2014 | $1,152,000 | +320.4% | 67,481 | +196.7% | 0.00% | – |
Q2 2014 | $274,000 | +77.9% | 22,746 | +24.3% | 0.00% | – |
Q1 2014 | $154,000 | +352.9% | 18,303 | +207.0% | 0.00% | – |
Q4 2013 | $34,000 | -96.2% | 5,962 | -96.4% | 0.00% | -100.0% |
Q3 2013 | $889,000 | – | 164,042 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
EMC Capital Management | 98,933 | $416,000 | 0.32% |
ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |